Skip to main content

Fibroid Doctors Slonim and Fischer Honored As Super Doctors by Texas Monthly

Respected fibroid doctors John Fischer, MD and Suzanne Slonim, MD were named Texas Super Doctors®. The honor is chosen by area doctors and recognized physicians by specialty. This is the 22nd year this annual award has been bestowed on area doctors.

-- TEXAS, USA (January 2026): Fibroid Institute Texas announces that fibroid doctors Suzanne Slonim, MD, and John Fischer, MD, were once again selected to Texas Super Doctors®. Super Doctors is in its 22nd year of naming noteworthy doctors in Texas Monthly magazine. All recipients were recognized by their peers for professional development, with doctors across the state voting for colleagues they trust. Candidates are independently evaluated by research staff, peer-reviewed by practice area based on professional achievements, leadership, and contributions, and checked for good standing and disciplinary history.

As a duo, Dr. Slonim and Dr. Fischer have been named Texas Super Doctors for 2024, 2025, and now 2026 at superdoctors.com.

Fibroid Institute Texas has become the go-to provider in the Dallas and Houston areas for in-clinic uterine fibroid embolization (UFE) as a non-surgical fibroid treatment. Their growing team of fibroid doctors is known for delivering compassionate, patient-centered care. Dr. Slonim and Dr. Fischer fulfill their passion for helping women live fibroid-free without major surgery or hospitalization.

“It’s an honor to be recognized and have our names listed alongside the best doctors our medical community has to offer—across all specialties. We are grateful,” Dr. Slonim said. “When a woman comes to us, our goal is to listen, offer a tailored treatment plan, and provide her with the best experience possible.”

Dr. Fischer agreed, adding, “This award is further proof that the work we are doing on fibroid relief without surgery is making an impact—not just with our patients but also among our colleagues and referral partners in the medical community. Our goal has always been to do all we can to promote awareness of fibroid education and treatment options.”

More About Fibroid Institute’s Role in Fibroid Treatment

Fibroid Institute is more than a fibroid treatment facility. Its specialized physicians and fibroid care team are committed to being thought leaders and raising awareness about fibroids and their impact on women’s health. Research shows that an estimated 171 million women worldwide are affected by fibroids, yet many remain unaware they have them. They also lack access to accurate information or care and potentially normalize their symptoms. Dr. Suzanne Slonim and Dr. John Fischer—both board-certified interventional radiologists and fibroid specialists skilled in minimally invasive, X-ray-guided procedures—are dedicated to bringing greater awareness to this critical women’s health issue.

Several years ago, Dr. Slonim was at the forefront of legislation that made Texas one of 10 states to recognize July as Uterine Fibroid Awareness Month. Since then, both fibroid doctors have pushed for local county and city governments to officially recognize Fibroid Awareness Month with proclamations and resolutions. With over 40,000 interventional radiology cases throughout their decorated careers, Dr. Slonim’s and Dr. Fischer’s experience and commitment have helped thousands of women become fibroid-free without major surgery.

As Dr. Slonim states, “Once a woman is ready to proceed, she can expect superior care and a tailored approach to help her achieve over a 90% success rate in fibroid treatment. Essentially, she becomes free from fibroid symptoms.”

About Uterine Fibroids and UFE

Uterine fibroids are non-cancerous growths in the uterus that affect 70-80% of all women, usually between ages 30 and 50. While not life-threatening, they can cause significant symptoms like severe pelvic pain, heavy periods, bloating, frequent urination, back pain, weight gain, anemia, pain during sex, and reproductive issues such as infertility or miscarriage.

Uterine fibroid embolization (UFE) is a minimally invasive, non-surgical treatment that uses image-guided interventional radiology. Experienced fibroid doctors insert a small catheter through the wrist, which delivers microscopic particles to block blood flow to the fibroids, causing them to shrink and die. UFE offers a safe and effective alternative to hysterectomy (uterus removal) or myomectomy (surgical fibroid removal). Covered by most insurance plans, the procedure has a shorter recovery time than traditional surgery plus a success rate of over 90%.

Although UFE was once less commonly recommended due to concerns about pain, since the Fibroid Institute's launch in 2016, a growing number of medical professionals have chosen to send referrals. The fibroid practice’s proprietary unique approach in fibroid treatment greatly reduces discomfort during recovery, making it a preferred option for many healthcare professionals.

About Fibroid Institute

Medical Director Dr. Suzanne Slonim founded Fibroid Institute in 2016 out of concern over the high number of surgeries used to treat uterine fibroids. Dr. Fischer joined in September 2022, bringing more than two decades of experience as one of the nation’s most respected fibroid specialists. Together, Drs. Slonim and Fischer—along with the entire Fibroid Institute team—are committed to expanding access to a minimally invasive treatment known as uterine fibroid embolization (UFE) and educating women about their full range of fibroid treatment options.

“Beyond believing wholeheartedly in the benefits of UFE, our concierge model at Fibroid Institute means patients get personalized and complete care from the initial consultation through post-procedure follow-ups,” Dr. Slonim said. “UFE patients can access their fibroid doctor’s mobile number to call or text with questions and concerns.”

Fibroid Institute is dedicated to prioritizing patient care and helping reduce healthcare costs associated with fibroid treatment. Uterine fibroid embolization (UFE) is an outpatient procedure that eliminates the need for a hospital stay, making it more cost effective than traditional surgeries. With a growing national demand for non-surgical fibroid treatment, patients from across the country visit the practice’s Houston and Dallas fibroid clinics. Thousands of women have trusted the Fibroid Institute team for safe and effective non-surgical care.

For More Information

In the North Texas area, patients can visit Fibroid Institute in Addison, Dallas, Duncanville and Euless. In the South Texas area, Fibroid Institute has consultations available to patients from Sugar Land, Katy, Clear Lake and The Woodlands. Appointments are also available via telemedicine in both metropolitan areas. For more information or to schedule, contact the Fibroid Institute’s Dallas fibroid clinics at 214-838-6440, Houston fibroid clinics at 713-903-3733 or visit FibroidFree.com.

Contact Info:
Name: Fibroid Institute
Email: Send Email
Organization: Fibroid Institute Texas
Address: 12700 Hillcrest Road, Suite 258, Dallas, Texas 75230, United States
Phone: +1-214-838-6440
Website: https://www.fibroidfree.com/

Source: PressCable

Release ID: 89180104

In case of identifying any problems, concerns, or inaccuracies in the content shared in this press release, or if a press release needs to be taken down, we urge you to notify us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your concerns and take swift action within 8 hours to rectify any issues identified or assist with the removal process. We are committed to delivering high-quality content and ensuring accuracy for our valued readers.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  241.56
+0.00 (0.00%)
AAPL  260.33
+0.00 (0.00%)
AMD  210.02
+0.00 (0.00%)
BAC  55.64
+0.00 (0.00%)
GOOG  322.43
+0.00 (0.00%)
META  648.69
+0.00 (0.00%)
MSFT  483.47
+0.00 (0.00%)
NVDA  189.11
+0.00 (0.00%)
ORCL  192.84
+0.00 (0.00%)
TSLA  431.41
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.